Grafana Cloud Unveils Adaptive Logs Drop Rules: Instantly Slash Log Noise and Costs
Breaking News – Grafana Cloud has launched a public preview of Adaptive Logs drop rules, enabling platform teams to eliminate wasteful log lines before they are ingested, reducing noise and cutting costs immediately.
“With drop rules, teams can now define custom logic to drop low-value logs—like health checks or debug messages—without touching infrastructure code,” said a Grafana product manager. “It’s a direct way to stop paying for log noise.”
Background
Most observability teams deal with logs they know are pure noise: throwaway health checks, forgotten DEBUG statements, or verbose INFO from rarely used services. These logs inflate storage and processing bills without providing insight.
“The hard part was always getting rid of them without changing every application’s configuration,” noted a senior observability engineer. “Now there’s a simple, centralized tool.”
How Drop Rules Work
Drop rules are evaluated in priority order when a log line arrives in Grafana Cloud. They are one of three mechanisms in Adaptive Logs:
- Exemptions – Protected logs pass untouched.
- Drop rules – Custom rules apply a drop percentage or 100% drop.
- Patterns – Optimization recommendations handle remaining logs.
Users can create rules based on log labels, detected log levels, or line content. Examples include dropping all DEBUG logs, sampling repetitive logs by a percentage, or targeting a specific noisy service with a label selector.
What This Means
This update means teams no longer need complex configuration changes to remove unwanted logs. A single rule can enforce standards across all services, saving money and reducing storage load.
“Drop rules complement our existing intelligent recommendations, giving teams full control over log cost management,” a Grafana engineer explained. “It’s a complete system: exemptions protect critical data, drop rules eliminate known noise, and patterns handle the rest.”
For more details, visit the official Adaptive Logs documentation.
Related Articles
- Mother Behind Custom Drug for Rare Mutation Launches New Biotech to Scale Personalized Treatments
- BeOne Secures FDA Approval for Lymphoma CAR-T, Outpacing Rivals in Cell Therapy Race
- Major Study Finds Alzheimer's Amyloid Drugs Ineffective, Pose Brain Swelling Risks
- Weak Evidence Fuels Rush to Ban Social Media for Minors, Researchers Warn
- Questionable Research Behind Youth Social Media Bans: A Closer Look at the Evidence
- FDA's New Gene Therapy Pathways: Skipping Trials for Rare Diseases?
- New 12-Metric Framework Unveiled for Evaluating Production AI Agents Based on 100+ Deployments
- How to Implement Single-Vesicle Profiling for Next-Generation Liquid Biopsies